JP2012001565A5 - - Google Patents

Download PDF

Info

Publication number
JP2012001565A5
JP2012001565A5 JP2011219630A JP2011219630A JP2012001565A5 JP 2012001565 A5 JP2012001565 A5 JP 2012001565A5 JP 2011219630 A JP2011219630 A JP 2011219630A JP 2011219630 A JP2011219630 A JP 2011219630A JP 2012001565 A5 JP2012001565 A5 JP 2012001565A5
Authority
JP
Japan
Prior art keywords
patient
immunogenic composition
influenza virus
langerhans cells
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011219630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012001565A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012001565A publication Critical patent/JP2012001565A/ja
Publication of JP2012001565A5 publication Critical patent/JP2012001565A5/ja
Pending legal-status Critical Current

Links

JP2011219630A 2004-11-03 2011-10-03 インフルエンザワクチン接種 Pending JP2012001565A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62497304P 2004-11-03 2004-11-03
US60/624,973 2004-11-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007540074A Division JP2008519042A (ja) 2004-11-03 2005-11-03 インフルエンザワクチン接種

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014081555A Division JP2014132035A (ja) 2004-11-03 2014-04-11 インフルエンザワクチン接種

Publications (2)

Publication Number Publication Date
JP2012001565A JP2012001565A (ja) 2012-01-05
JP2012001565A5 true JP2012001565A5 (enExample) 2013-04-11

Family

ID=36578359

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007540074A Pending JP2008519042A (ja) 2004-11-03 2005-11-03 インフルエンザワクチン接種
JP2011219630A Pending JP2012001565A (ja) 2004-11-03 2011-10-03 インフルエンザワクチン接種
JP2014081555A Pending JP2014132035A (ja) 2004-11-03 2014-04-11 インフルエンザワクチン接種

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007540074A Pending JP2008519042A (ja) 2004-11-03 2005-11-03 インフルエンザワクチン接種

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014081555A Pending JP2014132035A (ja) 2004-11-03 2014-04-11 インフルエンザワクチン接種

Country Status (9)

Country Link
US (2) US20090004222A1 (enExample)
EP (2) EP2923711A1 (enExample)
JP (3) JP2008519042A (enExample)
CN (1) CN101076355A (enExample)
AU (1) AU2005314563B2 (enExample)
CA (1) CA2586690A1 (enExample)
ES (1) ES2542020T3 (enExample)
HK (1) HK1214534A1 (enExample)
WO (1) WO2006062637A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1633312A4 (en) 2003-06-16 2012-09-26 Medimmune Llc INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
ES2527503T3 (es) 2005-03-08 2015-01-26 Medimmune, Llc Virus influenza reordenantes
US8591914B2 (en) * 2008-07-11 2013-11-26 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
CN102112151A (zh) 2008-07-30 2011-06-29 久光制药株式会社 微针装置及由微针装置使日本脑炎病毒抗原的功效升高的方法
EP2758075B1 (en) * 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
US9827190B2 (en) * 2013-02-01 2017-11-28 Glaxosmithkline Biologicals Sa Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
WO2019086463A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111971066B (zh) * 2018-01-18 2025-03-11 伊泽阿恩埃免疫疗法股份有限公司 脂质纳米颗粒
WO2020219719A1 (en) 2019-04-24 2020-10-29 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
WO2021221973A1 (en) 2020-04-28 2021-11-04 Ticona Llc Microneedle assembly

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1122527A (en) 1979-05-15 1982-04-27 Karen K. Brown Influenza vaccine production in liquid cell culture
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
CA2054228A1 (en) 1990-10-30 1992-05-01 Masaharu Oki Muramyldipeptide derivatives and influenza vaccine comprising the derivatives
CA2156525A1 (en) 1993-02-19 1994-09-01 Susan Dillon Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
KR100310510B1 (ko) * 1993-03-23 2002-07-04 장 스테판느 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
GB9500788D0 (en) 1995-01-16 1995-03-08 Medeva Holdings Bv Vaccine compositions
WO1997014434A1 (en) 1995-10-20 1997-04-24 Davidson, Clifford, M. Influenza vaccine
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
TW570803B (en) 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
GB9725084D0 (en) 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
AT408615B (de) 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
US6843781B2 (en) * 1999-10-14 2005-01-18 Becton, Dickinson And Company Intradermal needle
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
EP1361890B1 (en) 2001-02-23 2011-03-30 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
WO2002067983A1 (en) * 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Novel vaccine
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
CN1253220C (zh) * 2001-06-29 2006-04-26 贝克顿迪肯森公司 通过微管在真皮内输入疫苗和基因治疗剂
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20050123550A1 (en) 2003-05-12 2005-06-09 Laurent Philippe E. Molecules enhancing dermal delivery of influenza vaccines
US7588774B2 (en) * 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
CN101124343A (zh) * 2004-04-01 2008-02-13 阿尔扎公司 用于经皮肤输送流感疫苗的装置和方法
CA2690196A1 (en) * 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide

Similar Documents

Publication Publication Date Title
JP6247639B2 (ja) 経鼻インフルエンザワクチン組成物
JP2009173664A5 (enExample)
AR083361A1 (es) Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
WO2006060710A3 (en) Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
TW200722101A (en) Novel composition
NZ585674A (en) Vaccination with multiple clades of h5 influenza a virus
JP2013505205A5 (enExample)
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
JP2008534467A5 (enExample)
WO2007095976A3 (de) Adjuvanz in form einer lipid-modifizierten nukleinsäure
WO2013098655A9 (en) Vaccines directed against human enteroviruses
JP2009539965A5 (enExample)
NZ597000A (en) Compositions and methods for administration of vaccines against dengue virus
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
JP2015520196A5 (enExample)
MX2011008923A (es) Composicion inmunogena.
WO2012122725A1 (zh) 疫苗注射剂及其制备方法和用途
JP2015531389A5 (enExample)
HRP20141063T1 (hr) Cjepivo protiv hpv
JP2016531895A5 (enExample)
JP2014515035A5 (enExample)
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
MX2015006970A (es) Composiciones del virus del sindrome reproductor y respiratorio de porcino y sus usos.
JP2016521754A5 (enExample)